GLP-1 Nutrition Support
Compassionate, evidence-based care grounded in weight-inclusive principles.
Our Nutritional Focus
Many people taking GLP-1 medications struggle to eat enough due to reduced appetite and digestive side effects. We work with you to ensure you’re getting adequate nutrition to support your body’s needs, with particular attention to:
- Protein adequacy to preserve lean muscle mass and support metabolic health
- Fiber intake to promote digestive wellness and manage constipation
- Overall nutrient density to prevent deficiencies and maintain energy
- Regular eating patterns that work with your appetite and lifestyle
- Sufficient caloric intake to meet your body’s needs
We take a non-diet, Health at Every Size approach to GLP-1 agonist support, recognizing that these medications are a personal choice that deserves thoughtful, informed care. Our focus isn’t on restriction—it’s on nourishment, functionality, and helping you feel your best throughout your treatment.
Get Started With Us
Schedule with one of our expert nutritionist and dietitians today!
Why Nutrition Matters
How We Support You
We take a non-diet, Health at Every Size approach to GLP-1 agonist support, recognizing that these medications are a personal choice that deserves thoughtful, informed care. Our focus isn’t on restriction – it’s on nourishment, functionality, and helping you feel your best throughout your treatment.
Managing Side Effects
GLP-1 medications can bring digestive challenges including nausea, constipation, reflux, and changes in food tolerance. We’ll help you navigate these symptoms with practical, personalized strategies that make eating feel more comfortable and sustainable.
Holistic, Life-Enhancing Support
Our approach extends beyond nutrition to include:
- Strength training and movement strategies to maintain lean mass
- Mental health and emotional well-being support
- Sustainable lifestyle changes that enhance your quality of life
- Ongoing informed consent conversations about your treatment
- Recognition of the social, cultural, and systemic factors that impact health
Challenging Weight Stigma in Healthcare
We recognize that weight stigma and discrimination in healthcare settings create barriers to care. Our practice actively works to dismantle weight-based bias and create a respectful, compassionate environment where all bodies are honored. We understand that weight bias has historical ties to racial oppression and disproportionately impacts marginalized communities.
Our Values-Based Approach
We practice from a Health at Every Size® (HAES®) framework, aligned with the principles established by the Association for Size Diversity and Health (ASDAH) and supported by the Association for Weight and Size Inclusive Medicine (AWSIM). This means we reject the pathologization of body size and recognize that health exists on a continuum that varies for each individual.
We take a non-diet, weight-inclusive approach to GLP-1 agonist support, recognizing that these medications are a deeply personal choice that deserves thoughtful, informed care. Our focus isn’t on restriction or weight as a proxy for health—it’s on nourishment, functionality, and helping you feel your best throughout your treatment.
Whether you’re just beginning to explore GLP-1 agonist medications or have been taking them for a while, we’re here to support you with compassion, expertise, critical analysis, and deep respect for your individual journey and bodily autonomy.
Informed Consent & Critical Information
We believe in robust informed consent when it comes to GLP-1 medications. This includes discussing:
- The current limitations of long-term research on these medications
- Research showing that weight regain typically occurs when GLP-1 medications are discontinued
- The influence of pharmaceutical companies on public discourse around these drugs
- Potential side effects and adverse events
- Your autonomy in making healthcare decisions that align with your values
We draw on the work of researchers and advocates like Ragen Chastain, who examines weight science, weight stigma, and the evidence around GLP-1 medications to ensure our clients have access to comprehensive, unbiased information.
A Note on Evidence & Transparency
GLP-1 agonist medications are relatively new for weight loss purposes, and long-term research is still emerging. We’re committed to staying current with the evidence—including research that may be critical of these medications—and having honest, transparent conversations about what we know and what remains uncertain, so you can make informed decisions about your care.
I’m a patient of Chelsea Hemmenway, and I just wanted to tell you how wonderful my experience with her has been.I’ve been doing IVF off and on over the past few years, and since last year I’ve had terrible constipation since going on a high dose of estrogen. Seeing Chelsea has basically saved me. Even though I’m still having stool issues (my GP has sent me to a gastroenterologist as my problem may be liver related), Chelsea has helped me turn things around so that my IVF cycles are far more manageable. Additionally, she has given me long-term nutrition tips; I’ve learned so much from her over the past couple months. I feel so well cared for with Chelsea—she’s responsive and checks in with me. Chelsea also makes herself available for a last-minute appointment if I’m having a problem. I can’t tell you how much I wish I’d met someone like Chelsea when I started IVF in 2020 (we were living in the Bay Area at the time, and UCSF did not push nutritionists).Anyway, I just wanted you to know what a special practitioner I’ve found Chelsea to be. She’s been a bright spark in my journey with IVF, and I’m so glad to have met her!”